CN116370524A - 一种用于前列腺治疗的中药组合物及其制备方法 - Google Patents
一种用于前列腺治疗的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN116370524A CN116370524A CN202310477698.5A CN202310477698A CN116370524A CN 116370524 A CN116370524 A CN 116370524A CN 202310477698 A CN202310477698 A CN 202310477698A CN 116370524 A CN116370524 A CN 116370524A
- Authority
- CN
- China
- Prior art keywords
- traditional chinese
- chinese medicine
- medicine composition
- prostate
- fruit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 55
- 239000000203 mixture Substances 0.000 title claims abstract description 44
- 210000002307 prostate Anatomy 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 240000008790 Musa x paradisiaca Species 0.000 claims abstract description 24
- 235000003805 Musa ABB Group Nutrition 0.000 claims abstract description 21
- 235000015266 Plantago major Nutrition 0.000 claims abstract description 21
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 21
- 235000008113 selfheal Nutrition 0.000 claims abstract description 18
- 239000002023 wood Substances 0.000 claims abstract description 17
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 14
- 235000008397 ginger Nutrition 0.000 claims abstract description 14
- 241000208682 Liquidambar Species 0.000 claims abstract description 11
- 235000006552 Liquidambar styraciflua Nutrition 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims description 15
- 235000013399 edible fruits Nutrition 0.000 claims description 14
- 241000234314 Zingiber Species 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000012535 impurity Substances 0.000 claims description 9
- 238000009835 boiling Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 3
- -1 decoction Substances 0.000 claims description 3
- 235000001459 whitebark Nutrition 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims 1
- 230000027939 micturition Effects 0.000 abstract description 23
- 230000000694 effects Effects 0.000 abstract description 18
- 210000002700 urine Anatomy 0.000 abstract description 7
- 201000007094 prostatitis Diseases 0.000 abstract description 6
- 239000003053 toxin Substances 0.000 abstract description 6
- 231100000765 toxin Toxicity 0.000 abstract description 6
- 208000002193 Pain Diseases 0.000 abstract description 5
- 210000003734 kidney Anatomy 0.000 abstract description 5
- 235000011201 Ginkgo Nutrition 0.000 abstract description 4
- 244000194101 Ginkgo biloba Species 0.000 abstract description 4
- 235000008100 Ginkgo biloba Nutrition 0.000 abstract description 4
- 206010020718 hyperplasia Diseases 0.000 abstract description 4
- 206010063408 Bladder hypertrophy Diseases 0.000 abstract description 3
- 208000004434 Calcinosis Diseases 0.000 abstract description 3
- 230000002308 calcification Effects 0.000 abstract description 3
- 208000037157 Azotemia Diseases 0.000 abstract description 2
- 201000001881 impotence Diseases 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 208000009852 uremia Diseases 0.000 abstract description 2
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000005272 common selfheal Nutrition 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 12
- 229940079593 drug Drugs 0.000 description 7
- 210000005069 ears Anatomy 0.000 description 7
- 239000002504 physiological saline solution Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 241000272525 Anas platyrhynchos Species 0.000 description 5
- 210000003739 neck Anatomy 0.000 description 5
- 239000002994 raw material Substances 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 206010014025 Ear swelling Diseases 0.000 description 3
- 210000000683 abdominal cavity Anatomy 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000004908 prostatic fluid Anatomy 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 235000015512 Liquidambar formosana Nutrition 0.000 description 2
- 241000893545 Liquidambar formosana Species 0.000 description 2
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000004856 capillary permeability Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 208000017497 prostate disease Diseases 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000142952 Hamamelidaceae Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 235000010674 Prunella vulgaris Nutrition 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 206010046555 Urinary retention Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229940117173 croton oil Drugs 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229960003699 evans blue Drugs 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002390 hyperplastic effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 231100000861 limb weakness Toxicity 0.000 description 1
- 208000027905 limb weakness Diseases 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000037209 prostate health Effects 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于前列腺治疗的中药组合物及其制备方法,按照重量配比为:夏枯草100g、车前草100g、路路通50g、双白皮20g、分心木20g、生姜片15g,中药组合物可以排肾毒,清前列腺毒,及其引起的并发症,适用于小便刺痛,无力前列腺炎症,尿不干净,尿不出尿频尿急,尿毒症,阳萎,膀胱肥大,钙化,增生;夏枯草、车前草、路路通、双白皮、分心木为中药,药效温和,不易出现毒副作用,配合上辅料便于日常服用,服用三次有显著效果;服用中药组合物后能使尿液正常排出来,对于前列腺引起的尿频尿急,尿不出治疗效果好。
Description
技术领域
本发明涉及前列腺治疗技术领域,具体为一种用于前列腺治疗的中药组合物及其制备方法。
背景技术
当前,前列腺疾病,包括前列腺炎和前列腺增生是常见的一种疾病,特别是中老年的发病率更高,这种疾病的临床表现有尿频、尿多、尿急、尿痛、尿难、尿血、尿不尽、尿等待、尿潴留、尿道酸痛、四肢无力等多种不良症状。
目前治疗前列腺疾病的方法有很多,可采用手术或药物治疗,传统观点常以缩小增生的前列腺腺体,恢复尿道的通畅性为临床治疗的最初目的,并配合内服西药物快速治疗前列腺治及相关的疾病。
但是采用西药治疗,例如抗生素类药物治疗,使用不当或长期使用容易产生副作用,并且口服中西药物进行治疗时,长期服用药物不仅会对胃肠及肝、肾产生副作用,且药物不易进入前列腺,疗效不理想,抗生素不合理使用会导致耐药菌株增多,且不良反应发生率较高。
发明内容
本发明的目的在于提供一种用于前列腺治疗的中药组合物及其制备方法,以解决上述背景技术中提出的问题。
为实现上述目的,本发明提供如下技术方案:一种用于前列腺治疗的中药组合物,按照质量百分比计,包括夏枯草30-33%、车前草30-33%、路路通15-17%、双白皮6-8%、分心木6-8%、生姜片4-6%。
进一步的,按照重量配比为:夏枯草100g、车前草100g、路路通50g、双白皮20g、分心木20g、生姜片15g。
进一步的,还包括医学上可接受的辅料。
进一步的,所述组合物的剂型为口服液、汤剂、颗粒剂、散剂。
中药组合物的原料来源如下:
夏枯草:唇形科植物夏枯草的干燥果穗;
车前草:全草入药,归肝、肾、膀胱经;
路路通:为金缕梅科植物枫香树Liquidambar formosana Hance的干燥成熟果序;
双白皮:为桑科植物桑Morus alba L.的根皮,多在春、秋季挖取根部,南方各地冬季也可挖取,去净泥土及须根,趁鲜时刮去黄棕色粗皮,用刀纵向剖开皮部,以木槌轻击,使皮部与木部分离,除去木心,晒干;
分心木:为胡桃科植物胡桃Juglans regia L.果核内的木质隔膜。
本发明还提供一种用于前列腺治疗的中药组合物的制备方法,包括以下步骤:
步骤一、按照重量配比计,取出夏枯草、车前草、路路通、双白皮、分心木、生姜片,使用清水冲洗干净;
步骤二、使用医用纱布盛装夏枯草、车前草、路路通、双白皮、分心木、生姜片形成药包;
步骤三、将药包放进容器中并加水4000ml,煮3个小时;
步骤四、服用步骤三中的药汤。
进一步的,所述夏枯草的入药部位是干燥果穗,果穗除去杂质,然后晒干除去果穗的水分。
进一步的,所述车前草全株入药,车前草经过除杂质、洗净,切段、晒干处理。
进一步的,所述路路通为干燥成熟果序,除去路路通中包含的杂质,并洗净晒干。
与现有技术相比,本发明的有益效果是:本发明中夏枯草、车前草、路路通、双白皮、分心木为中药,药效温和,不易出现毒副作用,配合上辅料便于日常服用,服用三次有显著效果;
夏枯草可以清肝泻火,明目,散结消肿,主治用于目赤肿痛,目珠夜痛,头痛眩晕;车前草具备清热,利尿,祛痰,凉血,解毒的功效;路路通有祛风活络,利水,通经的作用;双白皮主治用于肺热喘咳痰,水饮停肺,胀满喘急,水肿,脚气,小便不利;分心木可以治疗涩精缩尿,止血止带,止泻痢;
本发明提供的中药组合物可以排肾毒,清前列腺毒,及其引起的并发症,适用于小便刺痛,无力前列腺炎症,尿不干净,尿不出尿频尿急,尿毒症,阳萎,膀胱肥大,钙化,增生;服用中药组合物后能使尿液正常排出来,对于前列腺引起的尿频尿急,尿不出治疗效果好。
具体实施方式
下面对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
本发明提供一种技术方案:一种用于前列腺治疗的中药组合物,按照质量百分比计,包括夏枯草30-33%、车前草30-33%、路路通15-17%、双白皮6-8%、分心木6-8%、生姜片4-6%。
一种用于前列腺治疗的中药组合物,按照重量配比为:夏枯草100g、车前草100g、路路通50g、双白皮20g、分心木20g、生姜片15g。
一种用于前列腺治疗的中药组合物,还包括医学上可接受的辅料,辅料采用鸭脖,鸭脖经过去皮处理,并将鸭脖切成厚片状。
所述组合物的剂型为口服液、汤剂、颗粒剂、散剂;
口服液和汤剂为组合物与鸭脖熬煮后药汤,颗粒剂可以对药汤进行浓缩并加工呈颗粒剂,散剂可以是字形购买相关药材,通过制备方法进行处理。
本发明还提供一种用于前列腺治疗的中药组合物的制备方法,包括以下步骤:
步骤一、按照重量配比计,取出夏枯草、车前草、路路通、双白皮、分心木、生姜片,使用清水冲洗干净;
步骤二、使用医用纱布盛装夏枯草、车前草、路路通、双白皮、分心木、生姜片形成药包;
步骤三、将药包放进容器中并加水4000ml,煮3个小时;
步骤四、服用步骤三中的药汤。
所述夏枯草的入药部位是干燥果穗,果穗除去杂质,然后晒干除去果穗的水分。
所述车前草全株入药,车前草经过除杂质、洗净,切段、晒干处理。
所述路路通为干燥成熟果序,除去路路通中包含的杂质,并洗净晒干。
实施例1,本发明中药组合物对小鼠耳肿胀的影响研究:
1.原料:夏枯草100g、车前草100g、路路通50g、双白皮20g、分心木20g、生姜片15g、水4000ml、鸭脖一条,熬煮3小时后,加盐并取药汤;
2.试验对象:ICR雄性小鼠60只;
3.处理方法:取体重误差在3-4g的雄性小鼠并分为三组,每组20只,分别为即为实施例1组,前列康组、生理盐水组,灌胃给药,每天给药1次,连续给药3天,最后在给药30-40min后,用2%巴豆油0.05ml涂于小鼠左耳两侧,4小时后脱椎处死,剪下左右耳,然后用9mm打孔器分别在同一部位取下圆耳片,使用扭力天平称重,计算耳壳重量,结果见表1;
组别信息 | 数量(只) | 耳肿胀度(毫克) |
实施例1组 | 20 | 8.6±3.9 |
前列康组 | 20 | 9.2±2.9 |
生理盐水组 | 20 | 10.5±3.3 |
表1实施例1的处理结果对照表
实验结果表明,本发明中药组合物实施例1组能减轻巴豆油所致的小鼠耳肿胀,与生理盐水组比较具有显著性差异(P<0.05),提示本发明中药组合物具有明显的抗炎作用。
实施例2,本发明中药组合物对小鼠腹腔毛细血管通透性增高的影响:
1.原料:夏枯草100g、车前草100g、路路通50g、双白皮20g、分心木20g、生姜片15g、水4000ml、鸭脖一条,熬煮3小时后,加盐并取药汤;
2.试验对象:ICR雄性小鼠30只;
3.处理方法:取体重误差在3-4g的雄性小鼠并分为三组,雌雄各半,分别是本发明实施例2组、生理盐水对照组、前列康阳性药物对照组,然后每组给予相应的本发明的药汤,阳性对照组给予灌胃前列康;空白对照组给予等容积的生理盐水,每天1次,连续3天,最后一次给药后1h,各组小鼠尾静脉注射0.5%伊文思蓝生理盐水溶液0.1ml/10g体重,然后立即腹腔注射0.6%醋酸0.2ml/只,20min后脱颈椎处死小鼠,剖开腹腔,用5ml生理盐水冲洗数次,收集洗液定容为10ml,离心1000rpm×5min,取上清液在分光光度计590nm处测OD值,比较各组间差异,结果见表2;
组别信息 | 数量(只) | OD值 |
实施例2组 | 10 | 0.351±0.072 |
前列康组 | 10 | 0.338±0.062 |
生理盐水组 | 10 | 0.261±0.051 |
表2实施例2的处理结果对照表
表2结果表明:本发明中药组合物均能显著抑制醋酸所致小鼠毛细血管通透性增高(P<0.05),表明本发明中药组合物有抑制炎症渗出,具有抗炎作用,效果良好。
实施例3,本发明中药组合物对前列腺炎病人的临床试验:
1.原料:夏枯草100g、车前草100g、路路通50g、双白皮20g、分心木20g、生姜片15g、水4000ml、鸭脖一条,熬煮3小时后,加盐并取药汤;
2.试验对象:年龄50岁~70岁之间的男性;
3.病例资料:符合良性前列腺增生症诊断标准,符合气虚血瘀证;
4.本组观察病例52例,均为门诊病例,分为治疗组和对照组,治疗组服用实施例3所得中药组合物,每天1次,连续3天,对照组服用其它胶囊药,连续3天;
5.疗效评价标准:治愈:治疗后,前列腺液的细菌培养结果呈阴性,镜检显示WBC低于10个/HP,患者无自觉症状;有效:治疗后,前列腺液的细菌培养结果呈阴性,镜检显示WBC低于10个/HP,患者自觉症状有明显改善;无效:治疗后,前列腺液的细菌培养结果呈阳性,镜检显示WBC>10个/HP,患者自觉症状无改善,治疗结果见表3;
疗效 | 痊愈人数 | 显效人数 | 有效人数 | 无效人数 |
实施例3组 | 16 | 4 | 5 | 1 |
对照组 | 8 | 4 | 7 | 7 |
表3前列腺炎病人的临床试验治疗结果表
服用本发明中药组合物总有效人数25人,占比96.2%,并且在治疗过程中,未见明显不良反应;
综上所述,本发明中药组合物在适用范围:小便刺痛、无力,前列腺炎症,尿不工净,尿不出,尿频尿急,膀胱肥大、钙化、增生。
服用组合三次起,具有以下功效:治疗膀胱肿瘤后遗症,使得尿液正常排出,治疗前列腺引起的尿频尿急。
尽管已经示出和描述了本发明的实施例,对于本领域的普通技术人员而言,可以理解在不脱离本发明的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由所附权利要求及其等同物限定。
Claims (9)
1.一种用于前列腺治疗的中药组合物,其特征在于:按照质量百分比计,包括夏枯草30-33%、车前草30-33%、路路通15-17%、双白皮6-8%、分心木6-8%、生姜片4-6%。
2.根据权利要求1所述的一种用于前列腺治疗的中药组合物,其特征在于:按照重量配比为:夏枯草100g、车前草100g、路路通50g、双白皮20g、分心木20g、生姜片15g。
3.根据权利要求1所述的一种用于前列腺治疗的中药组合物,其特征在于:还包括医用辅料。
4.根据权利要求2所述的一种用于前列腺治疗的中药组合物,其特征在于:所述组合物的剂型为口服液、汤剂、颗粒剂、散剂。
5.一种权利要求1-4任意一项所述的一种用于前列腺治疗的中药组合物的制备方法,其特征在于:包括以下步骤:
步骤一,按照重量配比计,取出夏枯草、车前草、路路通、双白皮、分心木、生姜片,使用清水冲洗干净;
步骤二,使用医用纱布盛装夏枯草、车前草、路路通、双白皮、分心木、生姜片形成药包;
步骤三,将药包放进容器中并加水4000ml,煮3个小时;
步骤四,服用步骤三中的药汤。
6.根据权利要求5所述的一种用于前列腺治疗的中药组合物的制备方法,其特征在于:所述夏枯草的入药部位是干燥果穗,果穗除去杂质,然后晒干除去果穗的水分。
7.根据权利要求5所述的一种用于前列腺治疗的中药组合物的制备方法,其特征在于:所述车前草全株入药,车前草经过除杂质、洗净,切段、晒干处理。
8.根据权利要求5所述的一种用于前列腺治疗的中药组合物的制备方法,其特征在于:所述路路通为干燥成熟果序,除去路路通中包含的杂质,并洗净晒干。
9.根据权利要求5所述的一种用于前列腺治疗的中药组合物的制备方法,其特征在于:所述步骤三中将医用辅料和药包一起放进容器中,混合浸泡均匀并熬煮。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310477698.5A CN116370524A (zh) | 2023-04-28 | 2023-04-28 | 一种用于前列腺治疗的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310477698.5A CN116370524A (zh) | 2023-04-28 | 2023-04-28 | 一种用于前列腺治疗的中药组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116370524A true CN116370524A (zh) | 2023-07-04 |
Family
ID=86961724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310477698.5A Pending CN116370524A (zh) | 2023-04-28 | 2023-04-28 | 一种用于前列腺治疗的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116370524A (zh) |
-
2023
- 2023-04-28 CN CN202310477698.5A patent/CN116370524A/zh active Pending
Non-Patent Citations (1)
Title |
---|
王修锋: "中药内外合治慢性前列腺炎87例", 甘肃中医学院学报, vol. 22, no. 01, pages 26 - 27 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102091203B (zh) | 一种治疗难愈性创面的外用中药制剂及其制备方法 | |
CN102205026A (zh) | 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 | |
CN115770279B (zh) | 用于治疗慢性下肢静脉疾病的中药组合物及其汤剂和制剂 | |
CN101569739A (zh) | 一种治疗胆囊炎的中药组合物及其制备方法 | |
CN103432485B (zh) | 一种治疗尿结石的中药制剂及制备方法 | |
CN103386101B (zh) | 一种治疗非特异性膀胱炎的中药制剂及其制备方法 | |
CN116370524A (zh) | 一种用于前列腺治疗的中药组合物及其制备方法 | |
CN110478416A (zh) | 治疗风湿性类风湿性关节炎的组合物及其制备方法和应用 | |
CN104971271A (zh) | 一种治疗瘀湿化热型前列腺增生的药物及制备方法 | |
CN1241596C (zh) | 治疗膀胱炎的口服中药制剂 | |
CN110251564B (zh) | 一种治疗痛风关节炎的外用药及其制备方法 | |
CN106943554A (zh) | 一种用于治疗急性肠炎的中药组合物 | |
CN113332365B (zh) | 一种复方紫草膏及其制备方法 | |
CN114028487B (zh) | 一种治疗急性软组织损伤的药物组合物及制剂 | |
CN102671036A (zh) | 治疗慢性肺脓肿中药口服液及制备方法 | |
CN114588233B (zh) | 一种治疗急性痛风的组合物 | |
CN106880758A (zh) | 一种用于外阴瘙痒和湿疹皮炎顽癣的中药制剂及制备方法 | |
CN105362823A (zh) | 一种治疗丹毒的中药制剂 | |
CN105709193A (zh) | 一种含有艾叶的治疗慢性肠炎的中药制剂及其制备方法 | |
CN105169342A (zh) | 一种治疗湿疹的中药组合物及其制备方法 | |
CN103610994B (zh) | 一种治疗肺脓肿的中药 | |
CN113018396A (zh) | 一种治疗复发性泌尿道感染的中药组合物及其制备方法 | |
CN105535383A (zh) | 一种促进皮肤创伤愈合的中药组合物及其制备方法 | |
CN105106692A (zh) | 一种用于胆结石术后恢复的中药组合物及其制备方法 | |
CN109528906A (zh) | 一种用于治疗输卵管堵塞和粘连的中药制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |